Welcome to LookChem.com Sign In|Join Free

CAS

  • or

25961-11-9

Post Buying Request

25961-11-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

25961-11-9 Usage

Uses

5-Acetyl-3-chloroiminodibenzyl is used as a reactant in various syntheses. It was used in the synthesis of solid pyridylzinc reagents with application in Negishi Reactions. Carbamazephine Impurity 1.

Check Digit Verification of cas no

The CAS Registry Mumber 25961-11-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,5,9,6 and 1 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 25961-11:
(7*2)+(6*5)+(5*9)+(4*6)+(3*1)+(2*1)+(1*1)=119
119 % 10 = 9
So 25961-11-9 is a valid CAS Registry Number.
InChI:InChI=1/C16H14ClNO/c1-11(19)18-15-5-3-2-4-12(15)6-7-13-8-9-14(17)10-16(13)18/h2-5,8-10H,6-7H2,1H3

25961-11-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)ethanone

1.2 Other means of identification

Product number -
Other names 3-Chloro-5-acetyliminodibenzyl

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:25961-11-9 SDS

25961-11-9Relevant articles and documents

LIPOXYGENASE INHIBITORS

-

Paragraph 00545-00547, (2021/10/02)

Various embodiments of the present disclosure are directed to compounds having Formula (I), Formula (IA), Formula (IB), Formula (IC), Formula (ID), Formula (IE), and/or pharmaceutically acceptable salts thereof. The compounds can be suitable for inhibiting lipoxygenases, and/or treating associated diseases, such as Alzheimer's disease. In some embodiments, the compounds may be administered to a patient as part of a pharmaceutical formulation.

An improved method for the preparation of 3-substituted 10,11-dihydro-5H-[b,f] azepine derivatives

Csende, Ferenc,Hosztafi, Sándor

, p. 587 - 589 (2007/10/03)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 25961-11-9